Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Pituitary adenylate cyclase activating polypeptide and migraine

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Responsiveness of outcome measures in myotonic dystrophy type 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. No effect of triheptanoin on exercise performance in McArdle disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Vancouver Declaration II on Global Headache Patient Advocacy 2019

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Pituitary adenylate cyclase activating peptide (PACAP) is found in human trigeminocervical complex and can trigger migraine. PACAP levels were measured using a sensitive radioimmunoassay. Stimulation of the superior sagittal sinus (SSS) in cat elevated PACAP levels in cranial blood. Patients with moderate or severe migraine headache had elevated PACAP in the external jugular vein during headache (n = 15), that was reduced 1 h after treatment with sumatriptan 6 mg (n = 11), and further reduced interictally (n = 9). The data suggest PACAP, or its receptors, are a promising target for migraine therapeutics.

Original languageEnglish
JournalAnnals of Clinical and Translational Neurology
Volume1
Issue number12
Pages (from-to)1036-40
Number of pages5
DOIs
Publication statusPublished - Dec 2014
Externally publishedYes

ID: 44854183